Ex Parte 6262013 et alDownload PDFPatent Trial and Appeal BoardAug 29, 201890013720 (P.T.A.B. Aug. 29, 2018) Copy Citation UNITED STATES PATENT AND TRADEMARK OFFICE UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 90/013,720 04/08/2016 6262013 5719.123677 2524 149890 7590 08/29/2018 SMITH BALUCH LLP 376 BOYLSTON ST STE 401 BOSTON, MA 02116 EXAMINER TORRES VELAZQUEZ, NORCA LIZ ART UNIT PAPER NUMBER 3991 MAIL DATE DELIVERY MODE 08/29/2018 PAPER Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 90/013,369 10/13/2014 6262013 5719.118309 1241 149890 7590 08/29/2018 SMITH BALUCH LLP 376 BOYLSTON ST STE 401 BOSTON, MA 02116 EXAMINER TORRES VELAZQUEZ, NORCA LIZ ART UNIT PAPER NUMBER 3991 MAIL DATE DELIVERY MODE 08/29/2018 PAPER Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE ____________ BEFORE THE PATENT TRIAL AND APPEAL BOARD ____________ Ex parte ECOLAB INC., Patent Owner and Appellant ____________ Appeal No. 2018-004716 Reexamination Control 90/013,369 & 90/013,720 Patent 6,262,013 Technology Center 3900 ____________ Before MARK NAGUMO, JEFFREY B. ROBERTSON, and WESLEY B. DERRICK, Administrative Patent Judges. DERRICK, Administrative Patent Judge. DECISION ON APPEAL Ecolab Inc. (“Patent Owner”), the real party in interest of U.S. Patent No. 6,262,013 (“the ’013 Patent”),1 appeals under 35 U.S.C. §§ 134(b) and 306 from a final rejection of claims 1–5, 10, 11, 15–20, and 25–32.2 Appeal Brief filed November 28, 2017 (“App. Br.”), 3; Final Office Action mailed May 15, 2017 (“Final Act.”). We have jurisdiction under 35 U.S.C. §§ 6, 134(b), and 306. We affirm. 1 U.S. Patent No. 6,262,013 B1 to Smith et al., issued July 17, 2001. 2 Originally issued claims 6–9, 12–14, and 21–24 were cancelled during reexamination. App. Br. 3. Claims 26–32 were added. Id. Appeal 2018-004716 Reexamination Control 90/013,369 & 90/013,720 Patent 6,262,013 2 STATEMENT OF THE CASE This merged reexamination proceeding arose out of two third-party requests for ex parte reexamination of the ’013 Patent filed by Patrick J. Smith of the law firm Greer, Burns & Crain, Ltd. on October 13, 2014 (Control 90/013,369), and April 8, 2016 (Control 90/013,720). A decision in Reexamination Control 90/013,369 was the subject of an appeal to the Board (Appeal No. 2016-004393); the Board affirmed the Examiner’s decision and entered a new ground of rejection (Decision on Appeal 2016- 004393, dated September 8, 2016 (“Board Dec.”)). The two reexamination proceedings were merged on January 24, 2017. The ’013 Patent states that the invention relates to improved laundry sour compositions that are used to provide desirable properties to garments that have been cleaned using alkaline detergent prior to being contacted with the laundry sour compositions. ’013 Patent 1:10–17. Independent claims 1, 15, and 25 are representative and read as follows (underlining and bracketing omitted): 1. A laundry process that provides cleaned, sanitized and pH neutralized laundry items, the process comprising: (a) contacting soiled laundry items with an alkaline detergent to form a treated laundry item; and (b) in a machine cycle at a temperature of less than about 70° C, contacting the treated laundry item with a peracid composition comprising at equilibrium about 5 to 15% hydrogen peroxide by weight, about 20 to 40% acetic acid by weight, and about 10 to 20% of the resulting organic peracid, peroxyacetic acid, by weight, wherein the composition is substantially free of other carboxylic acids and other peracids; wherein said composition neutralizes and sanitizes the laundry item; and thereafter Appeal 2018-004716 Reexamination Control 90/013,369 & 90/013,720 Patent 6,262,013 3 (c) rinsing the laundry items; (d) performing a separate sour soft step; and (e) performing an extraction step. 15. A laundry process, substantially free of a permanganate component, that cleans and sanitizes laundry items, the process comprising: (a) contacting a soiled laundry item with about 1 to 300 ounces of a laundry detergent chemical per hundred pounds of fabric laundry item, said laundry detergent comprising a source of alkalinity, and an anionic or nonionic surfactant in an aqueous medium, to remove soil to produce a treated laundry item; and (b) in a machine cycle at a temperature of less than about 70° C, contacting the treated laundry item with about 1 to 10 ounces of an aqueous peracid composition per hundred pounds of laundry item, said peracid composition comprising at equilibrium about 5 to 15% hydrogen peroxide by weight, about 20 to 40% acetic acid by weight, and about 10 to 20% of the resulting organic peracid, peroxyacetic acid, by weight, wherein the composition is substantially free of other carboxylic acids and other peracids; and thereafter (c) rinsing the laundry items; (d) performing a separate sour soft step; and (e) performing an extraction step. 25. A process for simultaneously sanitizing and pH neutralizing a laundry item treated with an alkaline detergent comprising contacting the treated laundry item with about 1 to 10 ounces of an aqueous peracid composition per hundred pounds of laundry item, wherein said peracid composition comprises at equilibrium about 5 to 15% hydrogen peroxide by weight, about 20 to 40% acetic acid by weight, and about 10 to 20% of the resulting organic peracid by weight, wherein the peracid is Appeal 2018-004716 Reexamination Control 90/013,369 & 90/013,720 Patent 6,262,013 4 peroxyacetic acid, wherein the composition is substantially free of other carboxylic acids and other peracids; and wherein the composition sanitizes the treated laundry item and neutralizes alkaline residues on the treated laundry item to a level that does not cause skin irritation. App. Br. (Claims App’x) 31, 33–36. The claims stand rejected under title 35 of the U.S. Code (pre-AIA) as follows: Claims 1–5, 10, 11, 15–20, 26, and 27 stand rejected under 35 U.S.C. § 112, first paragraph as failing to comply with the written description requirement; Claim 26 stands rejected under 35 U.S.C. § 112, second paragraph3 for indefiniteness; Claims 1–5, 10, 11, 15–20, and 25–32 stand rejected under 35 U.S.C. § 103(a) as unpatentable over Oakes4 in view of Tibbitts5 and Lozo;6 and Claims 1–5, 10, 11, 15–20, and 25–32 stand rejected under 35 U.S.C. § 103(a) as unpatentable over Oakes in view of Tibbitts, Lozo, and DE ’335.7 See Final Office Action, mailed May 15, 2017 (“Final Act.”); Examiner’s Answer, mailed January 18, 2018 (“Ans.”). 3 The Examiner cites 35 U.S.C. § 112(b) in the alternative. Final Act. 6. 4 Oakes et al., US 5,200,189, issued April 6, 1993 (also assigned to Ecolab). 5 Tibbitts, US 5,529,696, issued June 25, 1996. 6 Lozo, US 3,729,422, issued April 24, 1973. 7 Trabizsch, DE 39 29 335 A1, published July 3, 1991. Appeal 2018-004716 Reexamination Control 90/013,369 & 90/013,720 Patent 6,262,013 5 An oral hearing was held on July 11, 2018. A transcript of the oral hearing (“Transcript”) was entered into the record on August 6, 2018. Written Description Independent claims 1 and 15 both recite “performing a separate sour soft step”—step (d)—subsequent to two prior, recited steps, a first step using alkaline detergent to obtain a treated laundry item—step (a)—and a second step in which the treated laundry item is contacted with a peracid composition—step (b). App. Br. 31, 33–34. The Examiner finds that “there is no support for the claimed ‘separate sour soft step’” even if there is “support for ‘an optional softening step.’” Ans. 2–3 (citing ’013 Patent, 3:45–54). In essence, the Examiner maintains that there is support for a further softening step, but not for the particular type of softening step—a sour soft step. Id.; see also Final Act. 5–6. Patent Owner contends that there is written description support for a separate soft sour step because the ’013 Patent “discloses an optional softening step and equates ‘softening’ with ‘souring’ and ‘sour soft’ procedures.” Reply Br. 3. Patent Owner argues that “the ’013 patent uses the term ‘soften’ to mean ‘souring’, because the souring process renders the fabric compatible for human contact.” App. Br. 14 (citing Fast Declaration8 ¶ 26)). Paragraph 26 of the Fast Declaration states that “textiles with a high residual pH are skin irritants, are less soft, and are prone to fabric damage.” Patent Owner further argues that “softness is . . . used as a synonym for neutralization.” App. Br. 14–15 (citing ’013 Patent, 2:44–55). Column 2, 8 Declaration of Jonathan Fast, dated June 3, 2015. Appeal 2018-004716 Reexamination Control 90/013,369 & 90/013,720 Patent 6,262,013 6 lines 44 to 55, of the ’013 Patent includes the disclosure that “the compositions of the present invention can be used in a single step following an alkaline laundry detergent step . . . providing both softness and sanitizing.” ’013 Patent, 2:51–55. Having considered the cited testimony and disclosure, we find that while the souring process is reasonably considered a softening step, the meaning of softening step is not limited to a souring process. Thus, the disclosure of a separate softening step itself is not sufficient written description. The further fact that the disclosed single step souring process following an alkaline laundry detergent step provides softness, likewise, does not render the generic disclosure of a separate softening step into sufficient written description of a separate sour soft step after treatment of the laundry with a peracid composition. See, e.g., Tronzo v. Biomet, Inc., 156 F.3d 1154, 1158 (Fed. Cir. 1998) (“A disclosure in a patent application that merely renders the later-claimed invention obvious is not sufficient to meet the written description requirement; the disclosure must describe the claimed invention with all its limitations.”). Thus, on this record, we find that there is insufficient written description support for “performing a separate sour soft step.” Accordingly, we sustain the rejection of claims 1–5, 10, 11, 15–20, 26, and 27 for lack of written description. Indefiniteness The Examiner finds that there is insufficient antecedent basis for “of the sanitizing laundry sour” recited in claim 26. Final Act. 6–7. The Examiner determines “Claim 26 depends on [pending] independent claim 1 Appeal 2018-004716 Reexamination Control 90/013,369 & 90/013,720 Patent 6,262,013 7 that does NOT recite ‘the sanitizing laundry sour’ referred to by claim 26.” Ans. 3. The Examiner notes that an amendment filed July 14, 2017, which would have replaced “sanitizing laundry sour” with “peracid composition,” was not entered. Id. at 3–4; App. Br. 16. Patent Owner contends that “[a] person of ordinary skill would have easily seen that the ‘sanitizing laundry sour’ referred to in claim 26 is the ‘peracid composition’ of claim 1, because the ‘peracid composition’ is used to ‘sanitize and pH neutralize’ a laundry item in claim 1.” App. Br. 16; see also Reply Br. 6–8. Patent Owner further argues that “there is no doubt from the specification . . . that the sanitizing laundry sours are peracid compositions” and that “antecedent basis can be found by implication.” Reply Br. 7–8 (citing Slimfold Mfg. Co. v. Kinkead Indus., 810 F.2d 1113, 1116–17 (Fed. Cir. 1987)). As noted by Patent Owner (Reply Br. 7–8), in Slimfold, our reviewing court relied on the “specification show[ing] only one collar and in only one place” in rejecting an invalidity theory grounded on a lack of antecedent basis (Slimfold, 810 F.2d at 1116–17). The difficulty with Patent Owner’s position, however, is that the “sanitizing laundry sour” of claim 26 might also be taken to refer to the “separate sour soft step” of step (d) in claim 1 rather than to the “peracid composition . . . [that] neutralizes and sanitizes the laundry item” in step (b). While counsel at oral hearing contended that this is not the case because claim 26 recites that the laundry sour is sanitizing, only step (b) in claim 1 similarly relates to sanitizing, and the sour soft step of step (d) only requires neutralizing alkali (Transcript 17:9–15, 17:22–18:6), we note that step (d) at least uses the same term “sour” as used in claim 26. Where the invention is Appeal 2018-004716 Reexamination Control 90/013,369 & 90/013,720 Patent 6,262,013 8 disclosed to “relate[] to improved laundry sour compositions that provide other desirable properties to the cleaned garments” (’013 Patent, 1:15–17), particularly sanitization provided by an oxidant peracid component (id. at 2:58–3:9), it is not sufficiently clear that the sour soft step (d) only requires softening such that step (d) could not also reasonably be the antecedent for the “sanitizing laundry sour” of claim 26. Regarding Patent Owner’s request to “hold this formalistic issue for an eventual remand to the Examiner” because it “can easily be corrected on remand” (Reply Br. 8), we are apprised of no authority constraining us from reaching the merits of the rejection. Accordingly, we sustain the rejection of claim 26 as indefinite. Obviousness – Oakes in view of Tibbitts and Lozo The Examiner relies on Oakes for its disclosure of a peroxyacid antimicrobial concentrate and diluted end use composition comprising C1 to C4 peroxycarboxylic acid derived from a C1 to C4 carboxylic acid by reacting the carboxylic acid with hydrogen peroxide, including peroxyacetic acid derived from acetic acid reacted with hydrogen peroxide. Final Act. 8 (citing Oakes, 3:62–4:5, 4:18–21). As to the recited concentrations of hydrogen peroxide, acetic acid, and peroxyacetic acid in the peracid composition, the Examiner determines that the amounts of hydrogen peroxide and acetic acid are result effective variables as to the amount of peroxyacetic acid formed at equilibrium (id. at 15 (citing Board Dec. 21)) and, in noting the amount of peracetic acid can be increased to obtain the required sanitizing effect, that the amount of peroxyacetic acid is a result Appeal 2018-004716 Reexamination Control 90/013,369 & 90/013,720 Patent 6,262,013 9 effective variable as to the disinfecting or sterilizing results (id. at 16 (citing Oakes, 13:40–45)). Further, as highlighted by the Examiner, Oakes teaches use of an antimicrobial concentrate comprising 0.1 to 25 wt. % of a C1 to C4 peroxycarboxylic acid, which can be peroxyacetic acid, and about 1 to 50 wt. % hydrogen peroxide, in an equilibrium mixture.9 Ans. 4; see also Final Act. 15; Oakes, col. 4, ll. 2, 5–11, 26–28. The Examiner further determines that “it would be expected that the concentration of acetic acid in the equilibrium concentrate of Oak[e]s would also encompass the claimed amount.” Ans. 4–5. In effect, because the concentrations of acetic acid, hydrogen peroxide, and peroxyacetic acid at equilibrium are defined by an equilibrium constant, it is reasonably expected that the concentration of acetic acid at equilibrium would be that according to the claims when the concentrations of peroxyacetic acid and hydrogen peroxide are concentrations according to the claims. Oakes’ Example 6, cited in the prior Board Decision, and relied on by the Examiner, discloses a peracid composition with concentrations falling squarely within the recited ranges— 10.42% peracetic acid, 34% acetic acid, 10% H2O2, and 45.58% water. Oakes 10:15–19; Board Dec. 19–20; Ans. 5. The Examiner also relies on Oakes for its teaching that generally the “cleaning is accomplished with a different material such as a formulated 9 The Examiner also finds that “Oakes teaches that it was conventional to use a composition comprising acetic acid and peracetic acid, with no other carboxylic acids or percarboxylic acids” (Final Act. 16) and concludes “that a composition that is substantially free of other carboxylic acids, and other peracids is obvious in view of [Oakes]” (id.). Patent Owner does not contest either determination. See generally App. Br.; Reply Br. Appeal 2018-004716 Reexamination Control 90/013,369 & 90/013,720 Patent 6,262,013 10 detergent” and that “[a]fter this cleaning step, the sanitizing composition . . . [is] introduced . . . at a use solution concentration.” Final Act. 9 (citing Oakes, 7:31–38). The Examiner finds that “the concentrated [sanitizing] composition can be injected into the wash or rinse water of a laundry machine and contacted with contaminated fabric for a time sufficient to sanitize the fabric” at a “temperature[] in the range of about 4º to 60º C” and that “[e]xcess solution can then be removed by rinsing . . . the fabric.” Id. (citing Oakes, 8:4–15). As to the use of an alkaline detergent, the Examiner finds that alkaline detergent was conventional and that it would have been obvious to one of ordinary skill in the art at the time the invention was made to use an alkaline detergent composition in a laundry process as taught by Oakes.10 Id. at 9– 10; see also Board Dec. 6–7. As to neutralizing and sanitizing the laundry item, the Examiner finds that Oakes’ disclosed method of sanitizing clothing items or fabric fully meets the limitations because the sanitizing composition contains acid components that neutralize alkaline residues on the fabric. Final Act. 10. As explained by the Examiner, the sanitizing composition of Oakes containing acetic acid would be expected to neutralize alkaline residue. Id. As to “performing a separate sour soft step” (claims 1 and 15, step d), the Examiner relies on Tibbitts, which “relates to a commercial laundry process that includes alkaline laundry detergent solutions,” for its disclosure 10 As in the prior appeal (see Board Dec. at 6–7), Patent Owner does not dispute that the step of “contacting soiled laundry items with an alkaline detergent” would have been obvious to one of ordinary skill in the art (see generally App. Br.). Appeal 2018-004716 Reexamination Control 90/013,369 & 90/013,720 Patent 6,262,013 11 “that after washing the laundry is subjected to repeated rinses with fresh water and treated with a laundry sour if desired.” Id. (citing Tibbitts, Abstract, 1:6–8, 2:27–28, 4:44–53). Further, the Examiner relies on Lozo for its disclosure that “[o]ne of the main functions of a laundry sour is to neutralize excess alkalinity remaining in the freshly laundered garment so as to reduce skin irritation by the wearer of the garment.” Id. at 11; Lozo, 1:22–25. The Examiner determines that it would have been obvious to one of ordinary skill in the art at the time of the invention to have performed an additional neutralizing laundry sour in order to neutralize excess alkalinity, including so as to reduce skin irritation by the wearer of the garment. Final Act. 10–11. Patent Owner contends that the references do not teach or render obvious the claimed concentration limitations and that Oakes teaches away from the claimed process. Patent Owner contends that “nothing in the prior art discloses the concentration ranges in amended independent claims 1, 15, and 25” because the specific examples relied on in the Board Decision—examples 6 and 11– 13—have “values falling outside the claimed ranges.” See App. Br. 17–20. As to example 6, which the Board and the Examiner cited for a composition having 10.42% peracetic acid, 34% acetic acid, 10% H2O2, and 45.58% water (Board Dec. 19–20; Ans. 5; Oakes 10:15–19), Patent Owner contends that the cited component is not a sanitizing composition, but rather a composition used for forming the sanitizing compositions of Oakes (App. Br. 20; see also Transcript 4:9–14). Patent Owner provides neither evidence nor argument that the composition having 10.42% peracetic acid, 34% acetic Appeal 2018-004716 Reexamination Control 90/013,369 & 90/013,720 Patent 6,262,013 12 acid, 10% H2O2, and 45.58% water does not reflect the concentrations at equilibrium. See generally App. Br.; see also Transcript 4:15–21. Patent Owner also does not squarely address the Examiner’s determination that the disclosed encompassing ranges of both peroxycarboxylic acid, which can be peroxyacetic acid, and hydrogen peroxide of an antimicrobial concentrate in an equilibrium mixture would reasonably be expected to also include acetic acid in concentrations according to the claims. Reply Br. 10; see also generally App. Br. Rather, Patent Owner argues that “[i]t is not possible . . . to assume that the mere existence of equilibrium dictates certain concentrations” because, for example, the addition of 1 gram of each of peracetic acid, H2O2, and acetic acid in one liter of water would yield different concentrations of the three components than if 100 grams of each were added to the same volume. Reply Br. 10. This argument, however, is inapposite to the Examiner’s reasoning grounded on disclosed concentrations. Further, Patent Owner reasonably concedes that the concentration of peracetic acid at equilibrium with hydrogen peroxide and acetic acid is driven by the concentrations of hydrogen peroxide and acetic acid. Transcript 11:20–24. Patent Owner fails to further explain how the disclosed preferred antimicrobial concentrate in Oakes, as an equilibrium mixture, which comprises 0.1 to 25 wt. % of a C1 to C4 peroxycarboxylic acid, which can be peroxyacetic acid (3:62–4:11), and about 1 to 50 wt. % hydrogen peroxide (4:26–28), would not reasonably Appeal 2018-004716 Reexamination Control 90/013,369 & 90/013,720 Patent 6,262,013 13 lead one of ordinary skill to a concentration of acetic acid in the preferred antimicrobial concentrate within the scope of the claims.11 Patent Owner further contends that the Examiner’s reasoning is that if there are overlapping ranges for two of the components, that “then by necessity once those two components reach equilibrium, the third component will fall within the claimed ranges” and argues “that’s not technically accurate.” Transcript 7:6–10. This argument is unpersuasive of error because it fails to address the rejection grounded on disclosed concentrations of peroxyacetic acid and hydrogen peroxide at equilibrium in the antimicrobial concentrate, which also includes acetic acid at equilibrium, and the reasonable expectation as to the concentration of acetic acid. Patent Owner also contends that the Examiner has failed to establish the obviousness of the ranges on the basis of concentrations being result effective variables. App. Br. 20–23; Reply Br. 8–12. Patent Owner argues that the Examiner “has not shown that the concentration (or the amount) of hydrogen peroxide, acetic acid, or peracetic acid is a result-effective variable” (App. Br. 21) because “the Examiner does not even identify the intended ‘result’” (id. at 22). Patent Owner also argues that the fact the 11 While the preferred antimicrobial concentrate of Oakes also includes an amount of a C6 to C18 peroxyacid, the disclosed range of concentrations—as low as 0.01 wt. % (Oakes, 4:5–8)—includes amounts that reasonably would not be consequential to the equilibrium values of hydrogen peroxide, at 5– 15%, acetic acid, at 20–40%, and peracetic acid, at 10–20%. Moreover, Patent Owner does not proffer any cogent argument that Oakes teaches that the amount of acetic acid at equilibrium with peracetic acid and hydrogen peroxide is contrary to that claimed when the amounts of peracetic acid and hydrogen peroxide meet the claim limitations. See generally App. Br.; Reply Br. Appeal 2018-004716 Reexamination Control 90/013,369 & 90/013,720 Patent 6,262,013 14 parameters, i.e., concentration of hydrogen peroxide, acetic acid, and peracetic acid, are interrelated renders the Examiner’s rejection deficient because “the Examiner has not explained why the person of ordinary skill would have expected success, nor how the person of ordinary skill would have held some values constant (within the claimed ranges), while changing others to meet the claimed ranges.” Id. at 23. Patent Owner essentially reiterates these arguments in the Reply Brief, stating that: (1) adjusting the “amounts” of “hydrogen peroxide and acetic acid” would not have yielded the missing peracetic acid concentrations in Examples 6, 12 and 13 . . . , (2) the Examiner had not shown that the amounts of hydrogen peroxide and acetic acid were result-effective variables, (3) the Examiner did not specify what the intended “result” for the result-effective variable would have been, and (4) that the parameters were interrelated, and could not necessarily be changed independently. Reply Br. 9. Patent Owner contends that “[i]f a person of ordinary skill were to increase the peracetic acid concentration to increase the level of sanitization, this could not easily be done without affecting the other solution components” or the characteristics of the solution. Id. at 11. Patent Owner also contends that “[t]his analysis is complicated by the fact that the Examiner does not pick a starting point” as the different “starting points” “would require different modifications.” Id. at 11–12. Patent Owner fails to squarely address that the concentrations of acetic acid and hydrogen peroxide are identified as result effective variables for the formation of peracetic acid formed, and for sanitizing effect (Final Act. 15–16; Ans. 5), and that the concentration of peracetic acid is identified as a result effective variable for sanitizing effect (Final Act. 16; Ans. 4). “A Appeal 2018-004716 Reexamination Control 90/013,369 & 90/013,720 Patent 6,262,013 15 recognition in the prior art that a property [or a result] is affected by the variable is sufficient to find the variable result-effective.” In re Applied Materials, Inc., 692 F.3d 1289, 1297 (Fed. Cir. 2012). As to the contended difficulty in holding some variables constant such that they remain within recited ranges or the fact that the variables cannot be changed independently, on this record, we are not persuaded of error because the fact that variables are interrelated does not mean that optimizing the variables requires anything greater than the effort of a routineer. See Applied Materials, 692 F.3d at 1298 (Fed. Cir. 2012) (“The mere fact that multiple result-effective variables were combined does not necessarily render their combination beyond the capability of a person having ordinary skill in the art.”). Patent Owner’s contentions are not supported by any evidence of difficulties that could not have been overcome through routine effort in optimizing the concentrations of peracetic acid, hydrogen peroxide, and acetic acid at equilibrium. See generally Appeal Br.; Reply Br. Patent Owner further contends “that acetic acid is a result-effective variable for pH” and argues that this “would have led a person of ordinary skill . . . to maximize the amount of acid in the mixture, leading to an optimum above the claimed maximum of 40%” because Oakes “explains that biocidal activity . . . increases with decreasing pH.” App. Br. 22. This argument, however, fails to establish error because a prima facie case of obviousness does not require identifying optimal values, but only workable values within the disclosed ranges. See In re Aller, 220 F.2d 454, 456 (CCPA 1955) (“where the general conditions of a claim are disclosed in the Appeal 2018-004716 Reexamination Control 90/013,369 & 90/013,720 Patent 6,262,013 16 prior art, it is not inventive to discover the optimum or workable ranges by routine experimentation.”) (Emphasis added). In the same vein, Patent Owner contends that Oakes teaches away from the claimed process and does not provide a reasonable expectation of success in that the “sanitization according to [Oakes] functions best at pH values well below neutral.” App. Br. 24 (citing Oakes, 2:3–13); see also Reply Br. 12–13; Fast Declaration ¶ 66. While conceding that a “broadening statement in [Oakes] has a maximum pH of 8.0” (App. Br. 25 (citing Oakes, 2:55–56)), Patent Owner argues that “[a] person of ordinary skill desiring to sanitize using the [Oakes] compositions would have . . . been led to use a pH that is substantially lower than neutral” (id.). Patent Owner also relies on paragraphs 66 and 68–70 of the Fast Declaration as support for the contention that “[a] person of ordinary skill that uses [Oakes’] composition in a laundry process to effect sanitation would do so at a low pH, not the pH values one would expect for an alkaline laundry process.” App. Br. 25. We are not persuaded that there is a teaching away from the claimed process. See, e.g., DyStar Textilfarben GmbH & Co. Deutschland KG v. C.H. Patrick Co., 464 F.3d 1356, 1364 (Fed. Cir. 2006) (“We will not read into a reference a teaching away from a process where no such language exists.”). Oakes explicitly discloses that a pH of up to 8.0 can be used in its process, even if lower pH values are more effective for sanitizing effect. The declaration evidence is likewise unpersuasive. Paragraph 66 of the Fast Declaration does not adequately support the position that peracids would not be used at a pH of up to 8.0 because such a pH value is not equated with “the Appeal 2018-004716 Reexamination Control 90/013,369 & 90/013,720 Patent 6,262,013 17 high pH levels in laundry wash processes.” Fast Declaration ¶ 66. Moreover, the Fast Declaration’s criticism that the high concentrations required at “high pH levels” would be “expensive and difficult to achieve” (id.) is not persuasive evidence that one of ordinary skill in the art would have understood Oakes to teach away from the process. As explained by our reviewing court, “just because better alternatives exist in the prior art does not mean that an inferior combination is inapt for obviousness purposes.” In re Mouttet, 686 F.3d 1322, 1334 (Fed. Cir. 2012) (citing In re Gurley, 27 F.3d 551, 553 (Fed. Cir. 1994)). Paragraphs 68 and 69 of the Fast Declaration describe various experiments in Oakes II (U.S. Patent No. 5,437,868 (filed as a continuation-part of Oakes, Fast paragraph 68)), and paragraph 70 concludes that “like [Oakes], Oakes II suggests that peracids need a low pH value for effective sanitization” and that “[t]his is contrary to the use of peracids in laundry for sanitization.” Fast Declaration ¶¶ 68–70. These statements, however, fail to address that the workable, albeit less than optimal sanitizing effect contended, might still be sufficient, or that one of ordinary skill in the art would accept less than optimal sanitizing performance in obtaining other benefits, for example, the bleaching effect better obtained at higher pH values. See Fast Declaration ¶ 66. These statements also fail to address other factors impacting sanitizing performance, i.e., temperature and exposure time, highlighted by the Examiner. Ans. 4 (citing Oakes, 6:49–52); see also Oakes 7: 67–8:2 (explaining that “[h]igher use dilution can be employed if elevated use temperature (greater than 20º C.) or extended exposure time (greater than 30 seconds) are also employed.”), 8:65–66 (explaining that “heating may be Appeal 2018-004716 Reexamination Control 90/013,369 & 90/013,720 Patent 6,262,013 18 desirable to further enhance [the sanitizing composition’s] antimicrobial activity.”). Patent Owner further contends that “a person of ordinary skill . . . would have lacked a reasonable expectation of success (and in fact, would have expected failure) in achieving sanitation, given the relationship between pH and biocidal activity in [Oakes]” and that, in having been led to use a lower pH value, would have “no reason to use a separate sour soft step as required by the claims.” App. Br. 26; see also Reply Br. 14. On this record, we are not persuaded that a reasonable expectation of success was lacking, particularly where Patent Owner fails to address that the temperature and length of treatment, as well as the amount of peracid composition used, can be increased to improve the sanitizing effect. In re O’Farrell, 853 F.2d 894, 903–904 (Fed. Cir. 1988) (“Obviousness does not require absolute predictability of success. . . . all that is required is a reasonable expectation of success.”). As explained above, the cited portions of Oakes and the other cited evidence fail to establish that the relied on combination would not provide sanitization. Likewise, we are directed to no evidence that one of ordinary skill, looking to the cited evidence, would have not had a reasonable expectation of success. Patent Owner’s further argument that there would be no need for a separate sour soft step falls short because Patent Owner has failed to establish that Oakes teaches away from sanitizing laundry using its sanitizing composition at pH values up to 8.0. Appeal 2018-004716 Reexamination Control 90/013,369 & 90/013,720 Patent 6,262,013 19 Accordingly, on this record, we sustain the Examiner’s obviousness rejection of claims 1–5, 10, 11, 15–20, and 25–32 over Oakes in view of Tibbitts and Lozo. Obviousness – Oakes in view of Tibbitts, Lozo, and DE ’335 The Examiner relies Oakes, Tibbitts, and Lozo as set forth above, and further relies on DE ’335 “to show that neutralization would have been obvious during a disinfection (sanitizing) and acidification (sour).” Final Act. 13. DE ’335 provides a method for disinfection of textiles in continuous flow laundry systems. DE ’335, Abstract. DE ’335 discloses that Continuously operated continuous flow laundry systems normally function according to the counter-flow method, wherein fresh water and dirty laundry are fed at opposite ends into the continuous flow laundry system . . . and move more or less in opposite directions through the continuous flow laundry system. Id. at 3, ll. 7–10. DE ’335 further characterizes the process of washing textiles as a number of steps, distinguishing “between soaking, prewash, main wash, rinsing and the spin cycle or wringing.” Id. at 2, ll. 3–5. The Examiner relies on DE ’335 for disclosing the use of a mixture of an organic peroxyacid with an organic acid, which can be produced through mixing an aqueous H2O2 solution with the desired organic acid, for the “neutralization (‘acidification’)” of laundry. Final Act. 13–14 (citing DE ’335, 3, l. 29 to 4, l. 3, 5, ll. 6–16, 29–31). The Examiner further relies on DE ’335 for teaching that a solution comprising acetic acid and peracetic Appeal 2018-004716 Reexamination Control 90/013,369 & 90/013,720 Patent 6,262,013 20 acid is particularly preferred and for teaching that the final rinse bath should have a pH of 6 to 7. Id. The Examiner concludes that it would have been obvious to one of ordinary skill in the art at the time of the invention to have used the sanitizing compositions of Oakes in view of Tibbitts and Lozo to “neutralize alkaline residue on laundered items” as taught by DE ’335 in order to “provide for a laundry item with a pH that does not cause skin irritation.” Id. at 14. The Examiner also notes that “[t]he present claims do not require the use of a continuous flow laundry system.” Ans. 9. Patent Owner contends that DE ’335 teaches away from the claimed process in two ways. App. Br. 27. First, Patent Owner contends that “DE ’335 teaches to keep the Hydrogen Peroxide concentration ‘as low as possible’ and in any case less than 5%.” (id. (citing DE ’335, 6, ll. 5–6, 21–24)) and “that a low concentration of Hydrogen Peroxide is necessary to avoid high concentrations of active oxygen in the prewash zone of continuous washers, which could cause protein-containing contaminants to become affixed to the laundry” (id. (citing DE ’335, 4, ll. 22–28, 5, ll. 20–25)). Patent Owner contends this teaches away from the concentrations of hydrogen peroxide used in the claimed method. Id. Second, Patent Owner contends that “DE ’335 teaches that the sanitization and neutralization should occur in the final process step . . . because subsequent wet process steps after a sanitizing step can re-infect the laundry.” Id. at 27–28 (citing DE ’335, 4, ll. 5–19). Patent Owner contends this teaches away from the method of independent claims 1 and 15 because Appeal 2018-004716 Reexamination Control 90/013,369 & 90/013,720 Patent 6,262,013 21 they “require rinsing, sour soft and extraction steps after application of the peracid composition.” Id. Neither argument is well-founded because the teachings cited by Patent Owner relate to particular problems encountered in a continuous flow laundry system in which the fresh water and dirty laundry are fed at opposite ends and move in opposite directions. As DE’355 emphasizes, in a laundry system that does not include liquid from later laundry process steps in earlier process steps, the hydrogen peroxide included in the peracid composition would not contact any article in an earlier prewash zone. See, e.g., DE ’335, 2, ll. 3–5, 3, ll. 7–10. As such, the cited concern to limit the amount of active oxygen in a prewash zone, and preferences expressed in DE ’335 as to the maximum amount of H2O2, do not teach away from the process as claimed. Similarly, in a laundry system that carries out the final rinse step in the same drum as the main wash step, the entire machine is disinfected such that satisfactory results are obtained without use of a peracid composition in the final process step. Id. at 4, ll. 5–12; Ans. 9. Moreover, even for continuous flow laundry systems, DE ’335 discloses that daily disinfection when the system is shut down can be accomplished using “compounds that split off chlorine to the fresh water.” DE ’335, 4, ll. 16–21. We thus discern no teaching away in DE ’335 from a laundry process that requires rinsing, sour soft, and extraction steps after application of the peracid composition. Accordingly, on this record, we sustain the Examiner’s obviousness rejection of claims 1–5, 10, 11, 15–20, and 25–32 over Oakes in view of Tibbitts, Lozo, and DE ’335. Appeal 2018-004716 Reexamination Control 90/013,369 & 90/013,720 Patent 6,262,013 22 DECISION The Examiner’s decision to reject claims 1–5, 10, 11, 15–20, 26, and 27 under 35 U.S.C. § 112, first paragraph is affirmed. The Examiner’s decision to reject claim 26 under 35 U.S.C. § 112, sixth paragraph is affirmed. The Examiner’s decision to reject claims 1–5, 10, 11, 15–20, and 25– 32 under 35 U.S.C. § 103(a) is affirmed. Requests for extensions of time in this ex parte reexamination proceeding are governed by 37 C.F.R. § 1.550(c). See 37 C.F.R. § 41.50(f). AFFIRMED Appeal 2018-004716 Reexamination Control 90/013,369 & 90/013,720 Patent 6,262,013 23 FOR PATENT OWNER: SMITH BALUCH LLP 100 M ST SE STE 600 WASHINGTON, DC 20003 FOR THIRD-PARTY REQUESTER: GREER, BURNS & CRAIN, LTD 300 S. WACKER DR. SUITE 2500 CHICAGO, IL 60606 Copy with citationCopy as parenthetical citation